Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy.
Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.
Gynecol Oncol. 2023 Jul;174:49-54. doi: 10.1016/j.ygyno.2023.04.030. Epub 2023 May 5.
Accumulating evidence suggested the detrimental effects of adopting minimally invasive surgery in the management of early-stage cervical cancer. However, long-term evidence on the role of minimally invasive radical hysterectomy in "low-risk" patients exists.
This is multi-institutional retrospective study comparing minimally invasive and open radical hysterectomy in low-risk early-stage cervical cancer patients. A propensity-score matching algorithm (1:2) was used to allocate patients into the study groups. Kaplan-Meir model was used to estimate 10-year progression-free and overall survival.
Charts of 224 "low-risk" patients were retrieved. Overall, 50 patients undergoing radical hysterectomy were matched with 100 patients undergoing open radical hysterectomy. Minimally invasive radical hysterectomy was associated with a longer median operative time (224 (range, 100-310) vs. 184 (range, 150-240) minutes; p < 0.001), lower estimated blood loss (10 (10-100) vs. 200 (100-1000) ml, p < 0.001), and shorter length of hospital stay (3.8 (3-6) vs. 5.1 (4-12); p < 0.001). Surgical approach did not influence the risk of having intra-operative (4% vs. 1%; p = 0.257) and 90-day severe (grade 3+) postoperative complication rates (4% vs. 8%; p = 0.497). Ten-year disease-free survival was similar between groups (94% vs. 95%; p = 0.812; HR:1.195; 95%CI:0.275, 5.18). Ten-year overall survival was similar between groups (98% vs. 96%; p = 0.995; HR:0.994; 95%CI:0.182, 5.424).
Our study appears to support emerging evidence suggesting that, for low-risk patients, laparoscopic radical hysterectomy does not result in worse 10-year outcomes compared to the open approach. However, further research is needed and open abdominal radical hysterectomy remains the standard treatment for cervical cancer patients.
越来越多的证据表明,在早期宫颈癌的治疗中采用微创手术会产生不良影响。然而,在“低危”患者中,微创根治性子宫切除术的长期作用证据尚存在。
这是一项多机构回顾性研究,比较了低危早期宫颈癌患者中微创和开放根治性子宫切除术。采用倾向评分匹配算法(1:2)将患者分配到研究组。采用 Kaplan-Meier 模型估计 10 年无进展和总生存率。
共检索到 224 例“低危”患者的病历。总体而言,50 例行根治性子宫切除术的患者与 100 例行开放性根治性子宫切除术的患者相匹配。微创根治性子宫切除术的中位手术时间更长(224(范围,100-310)vs. 184(范围,150-240)分钟;p<0.001),估计出血量更少(10(10-100)vs. 200(100-1000)ml,p<0.001),住院时间更短(3.8(3-6)vs. 5.1(4-12);p<0.001)。手术方式并不影响术中(4% vs. 1%;p=0.257)和 90 天严重(3+级)术后并发症发生率(4% vs. 8%;p=0.497)的风险。两组 10 年无病生存率相似(94% vs. 95%;p=0.812;HR:1.195;95%CI:0.275,5.18)。两组 10 年总生存率相似(98% vs. 96%;p=0.995;HR:0.994;95%CI:0.182,5.424)。
我们的研究似乎支持新兴证据,即对于低危患者,腹腔镜根治性子宫切除术与开放性手术相比,不会导致 10 年预后更差。然而,还需要进一步的研究,开放腹式根治性子宫切除术仍然是宫颈癌患者的标准治疗方法。